Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents

Published:2017-05-07 Issue:3 Volume:33 Page:402-408
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Vermassen Tijl¹,Geboes Karen²,De Man Marc²,Laurent Stéphanie²,Decoene Elsie¹,Lumen Nicolaas³,Delanghe Joris⁴,Rottey Sylvie¹

Affiliation:

1. Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium

2. Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium

3. Department of Urology, Ghent University Hospital, Ghent, Belgium

4. Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/33/3/402/24196407/gfx063.pdf

Reference48 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

3. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206;Rini;J Clin Oncol,2010

4. Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G);Yamazaki;Ann Oncol,2016

5. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors;Motzer;Cancer,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A case of pseudo-acute kidney injury due to cyclin-dependent kinase inhibitor;Frontiers in Nephrology;2024-06-10

2. Combined creatinine/cystatin C equations for estimation of GFR in patients with cancer: the future is now!;Nephrology Dialysis Transplantation;2024-05-23

3. Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients;Clinical Kidney Journal;2024-01

4. Une élévation de créatininémie, autour d’un cas d’onco-néphrologie;Néphrologie & Thérapeutique;2023-06-01

5. Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker;Clinical Kidney Journal;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3